tiprankstipranks
Trending News
More News >
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market

Harvard Bioscience (HBIO) Ratios

Compare
277 Followers

Harvard Bioscience Ratios

HBIO's free cash flow for Q4 2025 was $0.48. For the 2025 fiscal year, HBIO's free cash flow was decreased by $ and operating cash flow was $2.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.20 2.20 0.82 1.85 2.20
Quick Ratio
1.25 1.25 0.40 0.92 1.06
Cash Ratio
0.39 0.39 0.07 0.16 0.19
Solvency Ratio
-0.77 -0.77 -0.09 0.06 -0.03
Operating Cash Flow Ratio
0.29 0.31 0.03 0.53 0.05
Short-Term Operating Cash Flow Coverage
4.25 4.41 0.04 2.39 0.30
Net Current Asset Value
$ -18.11M$ -18.11M$ -18.19M$ -15.25M$ -22.02M
Leverage Ratios
Debt-to-Assets Ratio
0.55 0.55 0.35 0.31 0.37
Debt-to-Equity Ratio
3.22 3.22 0.70 0.59 0.75
Debt-to-Capital Ratio
0.76 0.76 0.41 0.37 0.43
Long-Term Debt-to-Capital Ratio
0.72 0.72 0.00 0.30 0.37
Financial Leverage Ratio
5.83 5.83 2.00 1.88 2.01
Debt Service Coverage Ratio
0.93 0.93 -0.06 0.76 0.10
Interest Coverage Ratio
-0.13 -0.13 -1.94 0.53 -2.72
Debt to Market Cap
1.59 1.26 0.40 0.16 0.41
Interest Debt Per Share
11.08 11.08 10.96 1.09 1.37
Net Debt to EBITDA
6.71 6.71 -27.40 4.79 52.68
Profitability Margins
Gross Profit Margin
53.01%53.01%58.18%58.86%53.66%
EBIT Margin
-0.73%-0.73%-8.98%0.92%-5.85%
EBITDA Margin
6.14%6.14%-1.57%7.16%0.83%
Operating Profit Margin
-0.73%-0.73%-6.60%1.69%-6.12%
Pretax Profit Margin
-66.30%-66.30%-12.39%-2.28%-8.10%
Net Profit Margin
-65.51%-65.51%-13.18%-3.04%-8.40%
Continuous Operations Profit Margin
-65.51%-65.51%-13.18%-3.04%-8.40%
Net Income Per EBT
98.80%98.80%106.34%133.61%103.67%
EBT Per EBIT
9123.37%9123.37%187.81%-134.95%132.40%
Return on Assets (ROA)
-70.81%-70.81%-9.80%-2.49%-6.55%
Return on Equity (ROE)
-388.56%-412.84%-19.58%-4.67%-13.18%
Return on Capital Employed (ROCE)
-1.08%-1.08%-8.66%1.71%-5.68%
Return on Invested Capital (ROIC)
-1.04%-1.04%-5.66%1.60%-5.41%
Return on Tangible Assets
-90.18%-90.18%-20.96%-5.31%-13.98%
Earnings Yield
-242.37%-190.92%-13.50%-1.50%-8.30%
Efficiency Ratios
Receivables Turnover
5.39 5.39 6.33 6.97 6.78
Payables Turnover
11.14 11.14 8.22 8.31 8.15
Inventory Turnover
1.95 1.95 1.69 1.87 1.99
Fixed Asset Turnover
18.08 18.08 8.38 12.82 12.34
Asset Turnover
1.08 1.08 0.74 0.82 0.78
Working Capital Turnover Ratio
11.04 10.54 14.88 4.46 3.53
Cash Conversion Cycle
221.61 221.61 228.77 203.81 192.75
Days of Sales Outstanding
67.66 67.66 57.64 52.35 53.80
Days of Inventory Outstanding
186.73 186.73 215.51 195.36 183.76
Days of Payables Outstanding
32.78 32.78 44.38 43.90 44.81
Operating Cycle
254.39 254.39 273.15 247.70 237.56
Cash Flow Ratios
Operating Cash Flow Per Share
1.46 1.52 0.33 0.33 0.03
Free Cash Flow Per Share
1.14 1.26 -0.42 0.28 -0.01
CapEx Per Share
0.32 0.25 0.75 0.05 0.04
Free Cash Flow to Operating Cash Flow
0.78 0.83 -1.27 0.84 -0.38
Dividend Paid and CapEx Coverage Ratio
4.62 6.04 0.44 6.07 0.72
Capital Expenditure Coverage Ratio
4.62 6.04 0.44 6.07 0.72
Operating Cash Flow Coverage Ratio
0.15 0.15 0.03 0.33 0.02
Operating Cash Flow to Sales Ratio
0.07 0.08 0.02 0.12 0.01
Free Cash Flow Yield
21.53%18.91%-1.98%5.16%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.41 -0.52 -7.41 -66.46 -12.05
Price-to-Sales (P/S) Ratio
0.27 0.34 0.98 2.02 1.01
Price-to-Book (P/B) Ratio
1.70 2.16 1.45 3.11 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
4.65 5.29 -50.39 19.37 -261.90
Price-to-Operating Cash Flow Ratio
3.61 4.41 63.80 16.18 99.58
Price-to-Earnings Growth (PEG) Ratio
0.08 >-0.01 -0.03 1.02 >-0.01
Price-to-Fair Value
1.70 2.16 1.45 3.11 1.59
Enterprise Value Multiple
11.14 12.30 -89.72 33.04 174.20
Enterprise Value
59.23M 65.36M 132.25M 265.44M 164.45M
EV to EBITDA
11.14 12.30 -89.72 33.04 174.20
EV to Sales
0.68 0.76 1.40 2.36 1.45
EV to Free Cash Flow
11.68 11.64 -72.55 22.65 -375.45
EV to Operating Cash Flow
9.15 9.71 91.84 18.92 142.75
Tangible Book Value Per Share
-0.78 -0.78 -0.95 >-0.01 -0.12
Shareholders’ Equity Per Share
3.09 3.09 14.55 1.72 1.74
Tax and Other Ratios
Effective Tax Rate
0.01 0.01 -0.06 -0.34 -0.04
Revenue Per Share
19.50 19.50 21.62 2.65 2.74
Net Income Per Share
-12.77 -12.77 -2.85 -0.08 -0.23
Tax Burden
0.99 0.99 1.06 1.34 1.04
Interest Burden
91.23 91.23 1.38 -2.47 1.38
Research & Development to Revenue
0.10 0.10 0.11 0.10 0.11
SG&A to Revenue
0.20 0.20 0.23 0.20 0.22
Stock-Based Compensation to Revenue
0.01 -0.02 0.05 0.04 0.04
Income Quality
-0.11 -0.12 -0.12 -4.11 -0.12
Currency in USD